← Open Payments lookup

MICHELLE BEAMAN: Open Payments

NPI 1801404066 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,987 in 232 payments from 19 companies in 2025. Trend: 2023 $4,584 · 2024 $951 · 2025 $3,987

Food & beverage: $3,876Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.59$990
ABBVIE INC.44$412
Otsuka America Pharmaceutical, Inc.32$388
Teva Pharmaceuticals USA, Inc.13$378
Axsome Therapeutics, Inc.13$296
E.R. Squibb & Sons, L.L.C.11$227
Almatica Pharma LLC14$217
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$207
Indivior Inc.7$176
Lundbeck LLC11$155

Products named: INGREZZA, VRAYLAR, REXULTI, Auvelity, AUSTEDO XR, COBENFY, LOREEV XR, CAPLYTA.

Industry payments across NC — which companies pay providers there.